Delivery Order SPE2DB20D3103-SPE2DB25FP6E7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $16,566.76 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed price delivery order is scheduled for completion by September 12, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation and represents a continuation of AmerisourceBergen's substantial pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,120.36 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on September 10, 2025, with completion targeted for September 11, 2025. This firm fixed price delivery order was awarded on a competitive basis with no set-aside designation. The contract performs in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of DESCOVY 200-25 mg tablets (30-count units) with a ceiling value of $12,630.26. This competitively awarded, firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's substantial role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) valued at $20,629.38 under a firm fixed-price contract. The award was made on September 3, 2025, with an ultimate completion date of September 4, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform this delivery order from its corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $9,392.88 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,905.08 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This contract, awarded on August 8, 2025, with a completion date of August 11, 2025, represents a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $5,230.39 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This non-competitive, firm fixed-price delivery order represents a child award under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $36,331.88 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (quantity: 30 units) on August 12, 2025, with completion targeted for August 13, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded procurement of pharmaceutical supplies for federal medical needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $6,442.91 for DESCOVY 200-25 mg tablets in quantities of 30, with a firm fixed price and ultimate completion date of May 28, 2025. This non-set-aside contract was competitively awarded to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary operations. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $30,806.33 delivery order to AmerisourceBergen Drug Corp for 30-unit supplies of DESCOVY 200-25 mg tablets, with a completion date of June 26, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its Corporate Office location, leveraging its established role as a critical pharmaceutical distributor for federal military...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP6E7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,203.86 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) with an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The award represents a continuation of the company's role as a critical supplier within the federal medical supply chain, specifically supporting military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and runs through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates consistent capability to meet Defense Logistics Agency procurement requirements through open competition, with previous awards spanning diverse pharmaceutical products across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.2k | 7/24/25 |